Jordi Martí

Ashoka Fellow
Fellow Since 2011


This profile was prepared when Jordi Martí was elected to the Ashoka Fellowship in 2011.
The New Idea
Jordi is making early diagnosis and prevention of a wide spectrum of medical conditions available and affordable through a data-rich dry blood testing technology and strategy. He is working at two different levels to make this happen: Jordi is developing a new blood testing technology and also implementing a new business model that allows this solution to scale.

Jordi’s solution is integrated within local, regional and national governments, healthcare systems, and other key players in the country or region (citizen organizations, medical associations, or hospitals). He establishes different agreements with the health authorities to define the scope of the project based on an initial diagnosis of the most common pathologies among the population. These are tracked from both an individual as well as a population-wide perspective to help policymaking. Once general health needs and risk factors are identified, Jordi helps the government establish the methodology and infrastructure needed to analyze blood samples and to use the software that can process large volumes of data. To do this, Jordi is testing different business models and agreements. For instance, in Rio de Janeiro, he is working in partnership with Instituto Vital Brazil (a public company) to provide training to local staff, as well as follow-up, equipment, and all needed advisory services. He has also designed different sizes of labs to help reach scale while adjusting to local specific needs.

To drastically lower implementation costs by reaching an optimal volume, Jordi leverages his efforts on systems already in use by governments or other major health organizations to complement different awareness campaigns with testing. In these campaigns, he does not only include biochemistry parameters—his new technology—but important other indicators for other factors, such as HIV and covering large gaps of information from both the perspective of the patient and the authorities.

This method of capturing blood samples is simple, effective, and economic. It does not require special conditions for storage and transportation, and the investment in training the personnel that must handle the samples is minimal. All of these factors: Subsidized scaling, simplicity, leveraging local healthcare efforts and distribution channels, are each important for its introduction to the market, and together, open ample opportunities for scaling.
The Problem
The Strategy
The Person

More For You